Evaluation of Therapeutic Differences of Angiotensin II Receptor Blockers and Calcium Channel Blockers Among Hypertensive Patients Classified by Oriental Traditional Way

한국적 의학 기준에 근거한 고혈압환자의 Angiotensin II Receptor Blockers와 Calcium Channel Blockers의 약물 평가

  • Lee, Ok Sang (Laboratory of Clinical Pharmacy, Colleage of Pharmacy, Chungbuk National University) ;
  • Cheon, Young Ju (Laboratory of Clinical Pharmacy, College of Pharmacy, The Catholic University of Korea) ;
  • Ye, Kyong Nam (Laboratory of Clinical Pharmacy, College of Pharmacy, The Catholic University of Korea) ;
  • Yoon, Hee Young (Laboratory of Clinical Pharmacy, College of Pharmacy, The Catholic University of Korea) ;
  • Kim, Jung Tae (College of Pharmacy, Kyung Hee University Hospital at Gangdong) ;
  • Lee, Yun Jeong (College of Pharmacy, Dankook University) ;
  • Lim, Sung Cil (Laboratory of Clinical Pharmacy, College of Pharmacy, The Catholic University of Korea)
  • 이옥상 (충북대학교 약학대학) ;
  • 천영주 (가톨릭대학교 약학대학) ;
  • 예경남 (가톨릭대학교 약학대학) ;
  • 윤희영 (가톨릭대학교 약학대학) ;
  • 김정태 (경희대학교 약학대학, 강동경희대학교병원) ;
  • 이윤정 (단국대학교 약학대학) ;
  • 임성실 (가톨릭대학교 약학대학)
  • Received : 2014.03.03
  • Accepted : 2014.03.31
  • Published : 2014.04.30

Abstract

Background: Oriental lifestyle for treating diseases has been developed and well-accepted for a long time among Koreans. Sasang Constitution theory, originated from Korean traditional medicine, suggests that medication treatment should be differentiated by each patient's body classification (So-yang [SY], So-eum [SE], Tae-yang [TY], and Tae-eum [TE]), in contrary to western medicine's theory that medication should be applied equally by disease indication without such classification. However, the pharmacotherapeutic outcomes of these theories have not been compared to date. In this study, we aimed to compare the two theories by evaluating blood pressure (BP), which is lowered as a therapeutic outcome, among hypertensive patients taking angiotensin II receptor blockers (ARBs) or calcium channel blockers (CCBs), two most commonly used antihypertensive classes in Korea. Methods: From April 2006 to June 2012, we retrospectively collected data on hypertensive patients with Sasang Constitution classification at Kyunghee University Hospital at Gangdong, one of the East-West collaborative medical centers in Korea. We collected information on age, gender, underlying diseases, antihypertensive drugs (ARB, CCB, ARB+CCB), and BP by reviewing the electronic medical records. We excluded patients with missing blood pressure at baseline or follow-up, or those who had a change in their antihypertensive drug class during follow-up. Results: We selected a total of 573 patients (SY: 165, SE: 158, TY: 0, TE: 250). Baseline BPs were on average 139.0/82.0 mmHg for SY, 137.8/78.5 mmHg for SE, and 138.7/79.2 mmHg for TE. In all three groups, CCBs were the most prescribed, followed by combination therapy with ARB+CCB, then ARBs. BP reduction after 1 month of initial medication was significantly different among the drug classes, but not in Sasang constitutional classification (ARB [SY: -12.4/-4.7, SE: -12.3/-2.5, TE: -8.6/-1.8], CCB [SY: -12.3/-5.4, SE: -13.0/-2.3, TE: -10.8/-6.0], ARB+CCB [SY: -15.6/-6.7, SE: -18.4/-8.1, TE: -20.2/-6.7], drug [$P{\leq}0.05$/P>0.05], constitutional type [P>0.05/P>0.05]). Conclusion: We observed significant differences in reduction of blood pressure by classes of drugs (ARB+CCB>CCB>ARB) but not by Sasang constitutional classification. Therefore, current approach of antihypertensive pharmacotherapy assisted by Western medicine is appropriate for treatment of hypertension. However, further larger scale or prospective studies are required in order to confirm these results.

Keywords

References

  1. National Heart, Lung, and Blood Institute: The seventh report of the Joint National Committee on prevention, detection, evaluation andt reatment of high blood pressure, NIH Publication No.03-5233:2003.
  2. Rosendorff, C., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L., Kaplan, N. M., O'Connor, C. M., O'Gara, P. T. and Oparil, S. : Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115, 2761 (2007). https://doi.org/10.1161/CIRCULATIONAHA.107.183885
  3. Hazarus, J. M., Bourgoignie, J. J., Buckalew, V. M., Greene, T., Levey, A. S., Milas, N. C., Paranandi, L., Peterson, J. C., Porush, J. G., Rauch, S., Soucie, J. M. and Stollar, C. : Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension 29, 641 (1997). https://doi.org/10.1161/01.HYP.29.2.641
  4. Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H. and Westerling, S. : Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351, 1755 (1998). https://doi.org/10.1016/S0140-6736(98)04311-6
  5. Turnbull, F. : Effects of different blood-pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 362, 1527 (2003). https://doi.org/10.1016/S0140-6736(03)14739-3
  6. Jeon, E. Y. : The Effect of Sasang Constitutional Diet for Essential Hypertension on Blood Pressure, Fat, and Serum Lipid. Journal of Korean Academy of Nursing 32, 673 (2002). https://doi.org/10.4040/jkan.2002.32.5.673
  7. Kim, M., Yoo, J., Koh, S. and Park, J. : Prevalence of Hypertension and Risk Factors According to Sasang Constitution. J of Sasang Constitutional Medicine 21, 150 (2009).
  8. Koda-Kimble, M. A., Young, L. Y., Alldredge, B. K., Corelli, R. L., Gugliemo, B. J., Kradjan, W. A. and Wiliams, B. R. : Applied therapeutcis: The clinical use of drugs, 9th Ed, Philadephia, Lippincott (2009).
  9. Moreira, L. B., Fuches, F. D., Moraes, R. S., Bredemeiser, M. and Duncan, B. B. : Alcohol intake and blood pressure; the importance of time elapsed since last drink. Journal of Hypertension 16, 175 (1998). https://doi.org/10.1097/00004872-199816020-00007
  10. Lee, J. M. : Dong-Yi-Soo-Se-Bo-Won, Seoul, Republic of Korea (1894).
  11. Chae, H., Lyoon, I. K., Lee, S. J., Cho, S. H., Bae, H., Hong, M. and Shin, M. K. : An Alternative way to individualized medicine:Psychological and Physical traits of Sasang Typology. The Journal of Alternative and Complementary Medicine 9, 519 (2003). https://doi.org/10.1089/107555303322284811
  12. Shin, M. S., Han, C. H., Kim, B. Y., Kim, K. J., Park, S. H. and Choi, S. M. : A study on the recognition and actual condition of Korea medical doctors in oriental medical care of hypertension. The Journal of Korean Acupuncture & Moxibustion Society 25, 23 (2008).
  13. Kim, J. W., Yeo, H. R., Kim, K. K., Jung, S. H., Lee, M. Y. and Lee, Y. T. : Study on the Characteristics of Body shapes classified by Sasang Constitutions According to Age groups. Korean J. Oriental Physiology & Pathology 21, 258 (2007).
  14. Lee, T., Lee, S., Choe, B. and Song, I. : A Study on the Prevalences of Chronic Diseases according to Sasnag Constitution at a Health Examination Center. J of Sasang Constitutional Medicine 17, 32 (2005).
  15. Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., Franco, S., Fullerton, H. J., Gillespie, C., Hailpern, S. M., Heit, J. A., Howard, V. J., Huffman, M. D., Kissela, B. M., Kittner, S. J., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Magid, D., Marcus, G. M., Marelli, A., Matchar, D. B., McGuire, D. K., Mohler, E. R., Moy, C. S., Mussolino, M. E., Nichol, G., Paynter, N. P., Schreiner, P. J., Sorlie, P. D., Stein, J., Turan, T. N., Virani, S. S., Wong, N. D., Woo, D. and Turner, M. B. : Executive Summary: Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association. Circulation 127, 143 (2013). https://doi.org/10.1161/CIR.0b013e318282ab8f
  16. Lee, S. W., Kim, J. Y. and Jang, E. S. : Development of standard on constitutional health status. Korea Institution of Oriental Medicine 44 (2009).
  17. Korean Association of Pharmacy Education, Organiazion of Pharmacology, Pharmacology, 11th Ed. Seoul, Shinil (2009).
  18. Sung, Y. N., Jang, S. M., Lim, D. H., Shin, S., Song, H. and Lee, S. H. : Prescribing Patterns of Antihypertensive Drugs by outpatients with Hypertension in 2007. Kor. J. Clin. Pharm. 19, 167 (2009).
  19. The Task Force for the management of Arterial Hypertension of the European Society of Hypertension (SEH) and of the European Society of Cardiology (ESC), 2007 guidelines for the management of arterial hypertension. J Hypertens 25, 1105 (2007). https://doi.org/10.1097/HJH.0b013e3281fc975a
  20. Philipp, T., Smith, T. R., Glazer, R., Wernsing, M., Yen, J., Jin, J., Schneider, H. and Pospiech, R. : Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin. Ther. 29, 563 (2007). https://doi.org/10.1016/j.clinthera.2007.03.018
  21. Chrysant, S. G., Melino, M., Karki, S., Lee, J. and Heyrman, R. : The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-bline, controlled, 8-week factorial efficacy and safety study. Clin Ther 30, 587 (2008). https://doi.org/10.1016/j.clinthera.2008.04.002
  22. Neutel, J. M. : Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Curr. Med. Res. Opin. 24, 2389 (2008). https://doi.org/10.1185/03007990802262457
  23. Alan, H. G., Jan, M. B., Barry, L. C. and George, L. B. : Combination therapy in hypertension. Journal of the American Society of Hypertension 4, 90 (2010). https://doi.org/10.1016/j.jash.2010.03.001
  24. Lee, J. H. : Oriental medication of Hypertension. Journal of Korean Association of Health Promotion 23, 1739 (1999).